Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer

9 Oct 2020

Abstract excerpt

Background. Postoperative early biochemical recurrence (BCR) was an essential indicator for recurrence and distant metastasis of prostate cancer (PCa). The aim of this study was to construct a cancer stem cell- (CSC-) associated gene set-based signature to identify a subgroup of PCa patients who are at high risk of early BCR. Methods. The PCa dataset from The Cancer Genome Atlas (TCGA) was randomly separated into...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Ferroptosis and cancer prognosis
Share to GDF15 and Related Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33101546
DOI: 10.1155/2020/8860788

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate CancerPMID 33101546Read ↗

Identification and validation of a prognostic 5-protein signature for biochemical recurrence following radical prostatectomy in prostate cancerSemantic proximity Read ↗

Integrating Radiosensitivity Gene Signature Improves Prostate Cancer Outcome PredictionSemantic proximity Read ↗

Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.Semantic proximity Read ↗

A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate CancerSemantic proximity Read ↗

A potential panel of eight‑mRNAs signature for predicting biochemical recurrence‑free survival and disease‑free survival in prostate cancerSemantic proximity Read ↗

Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate CancerSemantic proximity Read ↗

A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA databaseSemantic proximity Read ↗

Machine Learning of Tumor Microenvironment Related Genes for Prostate Cancer Biochemical Recurrence Prediction and Immune AnalysisSemantic proximity Read ↗

5 Gleason score-associated gene signatures serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate AdenocarcinomaSemantic proximity Read ↗

ALDH3A2, ODF2, QSOX2, and MicroRNA-503-5p Expression to Forecast Recurrence in TMPRSS2-ERG-Positive Prostate CancerSemantic proximity Read ↗

A stemness-related seven-gene signature for predicting prognosis and treatment response in muscle invasive bladder cancerSemantic proximity Read ↗

Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.